SYNTHETIC AND ENDOGENOUS INHIBITORS OF SNAKE-VENOM METALLOPROTEINASES

被引:0
|
作者
ROBEVA, A
POLITI, V
SHANNON, JD
BJARNASON, JB
FOX, JW
机构
[1] UNIV VIRGINIA,CTR HLTH SCI,CHARLOTTESVILLE,VA 22908
[2] POLIFARMA RES CTR,ROME,ITALY
[3] UNIV ICELAND,REYKJAVIK,ICELAND
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The venoms of most Crotalidae snakes contain metalloproteinases which are the agents responsible for the production of venom-induced hemorrhage via proteolytic destruction of capillary basement membranes. Prevention of hemorrhage by administration of antiserum is generally not totally effective against damage at the site of envenomation. Therefore, we have investigated alternate methods for the alleviation of hemorrhage by inhibition of the proteolytic activity of the hemorrhagic toxins. The first approach involves the synthesis of carboxyalkyl peptide inhibitors in which the peptide moiety is modeled on the substrate specificity of the toxins. With this approach we have determined that the carboxypentyl group for interaction with the active site Zn++ ion is most effective. Also, longer peptide moieties enhance the inhibitors' activity giving K(i)'s in a range of 10(-6) M. Our second approach to hemorrhagic toxin inhibition was to search for the presence of endogenous inhibitors against the toxins in the venom. From the crude venom we have isolated several pyro-glutamate containing peptides, two of which are relatively good inhibitors of the toxins. The isolation and characterization of the endogenous toxin inhibitors as well as the synthetic inhibitors may ultimately serve as a basis for new, effective treatments against venom-induced hemorrhage.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 50 条
  • [21] SNAKE-VENOM POISONING IN ARIZONA
    RUSSELL, FE
    PICCHIONI, AL
    ARIZONA MEDICINE, 1977, 34 (07) : 457 - 462
  • [22] TREATMENT OF SNAKE-VENOM OPHTHALMIA
    LATH, NK
    PATEL, MM
    CENTRAL AFRICAN JOURNAL OF MEDICINE, 1984, 30 (09) : 175 - 176
  • [23] THE TAIPAN SNAKE-VENOM TIME
    MACKIE, IJ
    ROONEY, AM
    MCNALLY, T
    MACHIN, SJ
    BLOOD, 1993, 82 (10) : A408 - A408
  • [24] NOMENCLATURE OF SNAKE-VENOM TOXINS
    BOTES, DP
    CARLSSON, FH
    JOUBERT, FJ
    LOUW, AI
    STRYDOM, AJC
    STRYDOM, DJ
    VILJOEN, CC
    TOXICON, 1974, 12 (12) : 99 - 101
  • [25] NOMENCLATURE OF SNAKE-VENOM TOXINS
    BOTES, DP
    CARLSSON, FHH
    JOUBERT, FJ
    LOUW, AI
    STRYDOM, AJC
    STRYDOM, DJ
    VILJOEN, CC
    TOXICON, 1985, 23 (02) : 189 - 191
  • [26] SUICIDE BY SNAKE-VENOM INJECTION
    YADLOWSKI, JM
    TU, AT
    GARRIOTT, JC
    NORTON, LE
    JOURNAL OF FORENSIC SCIENCES, 1980, 25 (04) : 760 - 764
  • [27] OVERVIEW OF SNAKE-VENOM CHEMISTRY
    TU, AT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 4 - AGFD
  • [28] THERAPY WITH SNAKE-VENOM PROTEASES
    STRAUB, PW
    BULLETIN DER SCHWEIZERISCHEN AKADEMIE DER MEDIZINISCHEN WISSENSCHAFTEN, 1973, 29 (4-6): : 244 - 252
  • [29] INDIVIDUAL VARIATION IN SNAKE-VENOM
    WILLEMSE, GT
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1978, 61 (04): : 553 - 557
  • [30] MYOTOXIC SNAKE-VENOM FACTORS
    MEBS, D
    TOXICON, 1982, 20 (01) : 361 - 361